GUMM - Eliminate the Common Cold Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: DanZ who wrote (4250)	2/25/2003 9:22:59 PM
From: pz	Read Replies (2) of 5582

Dan, I guess I look at it a little differently than you do. I look at Zicam's market share as being close to being at it's peak, right or wrong. So any competition taking away it's market share is not positive. No matter what happens this is going to cost MTXX money, either in legal fees to fight off Quigley or in market share. By the way...my darling little 1 year old niece gave me her cold, so I'm currently taking Zicam and Claritin just in case it's allergies...lol. One of them has to work...right?...lol. I hope MTXX does well...but I sure don't see the stock doing anything but going sideways at best with this news. But like I say....what do I know. Paul

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next